HERON THERAPEUTICS, INC. /DE/ Logo

HERON THERAPEUTICS, INC. /DE/

Commercial-stage biotech developing therapies for acute care and oncology.

HRTX | US

Overview

Corporate Details

ISIN(s):
US4277461020
LEI:
Country:
United States of America
Address:
4242 CAMPUS POINT COURT, SUITE 200, 92121 SAN DIEGO

Description

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapies to address unmet medical needs in acute care and oncology. The company utilizes its proprietary drug delivery technologies to create novel, best-in-class treatments. Its product portfolio is designed to improve the lives of patients by providing solutions for significant medical issues, including postoperative pain management, with an aim to reduce opioid reliance, as well as managing postoperative and chemotherapy-induced nausea and vomiting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-06-23 22:28
FORM 3 SUBMISSION
English 9.7 KB
2023-06-23 22:19
8-K
English 157.5 KB
2023-06-12 22:41
FORM 3 SUBMISSION
English 10.0 KB
2023-06-12 15:10
8-K
English 245.6 KB
2023-05-24 23:04
FORM 4 SUBMISSION
English 7.1 KB
2023-05-11 22:11
10-Q
English 1.2 MB
2023-05-11 22:06
8-K
English 109.7 KB
2023-05-01 15:10
ARS
English 2.1 MB
2023-05-01 15:00
DEF 14A
English 4.4 MB
2023-04-20 22:06
PRE 14A
English 1.3 MB
2023-04-20 15:10
8-K
English 227.0 KB
2023-04-17 23:28
FORM 4 SUBMISSION
English 8.0 KB
2023-04-17 23:27
FORM 4 SUBMISSION
English 8.0 KB
2023-04-17 23:27
FORM 4 SUBMISSION
English 7.8 KB
2023-04-17 23:26
FORM 4 SUBMISSION
English 7.9 KB

Automate Your Workflow. Get a real-time feed of all HERON THERAPEUTICS, INC. /DE/ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HERON THERAPEUTICS, INC. /DE/

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HERON THERAPEUTICS, INC. /DE/ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.